Meta Mitchell has over twenty years experience in industrial research and development, specializing in realizing the potential of novel pharmaceuticals from scientific first concepts to commercial product. Areas of expertise include: Quality Assurance - controlling production and release of clinical supplies of new drug candidates or commercial drugs so as to minimize risks to human health and Quality Control - ensuring data and information has been correctly recorded, backed-up and interpreted. Meta has a Ph.D. in organic chemistry from Leeds University, UK. Her postgraduate research, performed in collaboration with Glaxo plc, was on the synthesis of broad spectrum anti-microbials.
The highlights of Meta’s professional career to date include direct involvement in the commercial launch of an anticancer drug that is currently used to treat ovarian cancer, the culmination of 15 years continuous work and investment. Meta was also a founder member of a successful start-up drug research and development company taking a drug into late stage, Phase III trials, of clinical research, which gained market approval for multiple myeloma and non-Hodgkin’s lymphoma.
Meta has expertise in Good Manufacturing Practice, Good Clinical Practice and Good Laboratory Practice, setting up Quality Assurance Systems, policies and procedures to support potential drugs through early and late stage development, and compliance and auditing. Meta currently consults in Quality Assurance, in particular focusing on clinical trial management.
